A carregar...
Reduction in oral corticosteroid use in patients receiving omalizumab for allergic asthma in the real-world setting
BACKGROUND: Oral corticosteroids (OCS) are commonly administered in patients with severe persistent allergic asthma. Despite their efficacy, they are associated with a wide variety of adverse events. The eXpeRience registry was set up to investigate real-world outcomes among patients receiving omali...
Na minha lista:
| Main Authors: | , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BioMed Central
2013
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3879326/ https://ncbi.nlm.nih.gov/pubmed/24305549 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1710-1492-9-47 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|